Yan Dong-Mei, Zhu Shuang-Li, Zhang Yong
World Health Organization Western Pacific Region Regional Reference Polio Laboratory, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):131-4.
To describe the source of vaccine-derived poliovirus (VDPV) and the effect on local polio-free status, the VP1 coding region was sequenced and analyzed for type I VDPV in Shanxi province in 2007.
The virus isolation was performed to double stool specimens from one case acute flaccid paralysis (AFP) patient. VP1 coding region of the isolated stain was sequenced and analyzed. The phylogenetic tree was constructed based on VP1 region sequence between Shanxi strains and other type I VDPVs.
2 type I + II +III strains were isolated from double stool specimens from the AFP patient in Shanxi Province in 2007. VP1 sequencing of the two stains revealed > 1.0% divergence from the VP1 region of P I /Sabin vaccine strain. According to WHO criteria, the two stains were identified as type I vaccine-derived poliovirus (VDPV). Phylogenetic analysis based on VP1 coding sequence showed that the evolution distance of Shanxi type I VDPV was far away from other VDPVs detected in China. Moreover, no evidence supported the AFP patient as immunodeficiency patient. So Shanxi type I VDPVs were classified into ambiguous VDPV(aVDPV).
Considering the genetic character for Shanxi type I VDPV and the local OPV coverage, we highly suspected that an immunodeficiency patient in local area who long-term excreted VDPVs existed and resulted in the patient infection of VDPV in Shanxi in 2007. In the post era of polio eradication, the detection and management for the possible existing patient of long-term excretion VDPV should be strengthened.
为描述疫苗衍生脊髓灰质炎病毒(VDPV)的来源及其对当地无脊髓灰质炎状态的影响,对2007年山西省I型VDPV的VP1编码区进行测序和分析。
对1例急性弛缓性麻痹(AFP)病例的双份粪便标本进行病毒分离。对分离株的VP1编码区进行测序和分析。根据山西省毒株与其他I型VDPV的VP1区序列构建系统发育树。
2007年从山西省AFP病例的双份粪便标本中分离出2株I + II +III型毒株。两株毒株的VP1测序显示与P I /Sabin疫苗株的VP1区存在>1.0%的差异。根据世界卫生组织标准,这两株毒株被鉴定为I型疫苗衍生脊髓灰质炎病毒(VDPV)。基于VP1编码序列的系统发育分析表明,山西省I型VDPV的进化距离与在中国检测到的其他VDPV较远。此外,没有证据支持该AFP患者为免疫缺陷患者。因此,山西省I型VDPV被归类为疑似VDPV(aVDPV)。
考虑到山西省I型VDPV的遗传特征和当地OPV接种率,我们高度怀疑当地存在一名长期排泄VDPV的免疫缺陷患者,并导致了2007年山西省该患者感染VDPV。在脊髓灰质炎根除的后时代,应加强对可能存在的长期排泄VDPV患者的检测和管理。